Jennifer L Taubert is EVP, WWC. Innovative Medicine of JOHNSON & JOHNSON. Currently has a direct ownership of 154,851 shares of JNJ, which is worth approximately $23.7 Million. The most recent transaction as insider was on Feb 11, 2019, when has been sold 1,599 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 155K
0% 3M change
9.5% 12M change
Total Value Held $23.7 Million

Jennifer L Taubert Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 11 2019
BUY
Grant, award, or other acquisition
-
1,599 Added 1.96%
79,987 Common Stock
Feb 11 2019
BUY
Exercise of conversion of derivative security
-
9,748 Added 11.06%
78,388 Common Stock
Feb 08 2019
SELL
Payment of exercise price or tax liability
$470,580 $132.0 p/Share
3,565 Reduced 4.94%
68,640 Common Stock
Feb 08 2019
BUY
Exercise of conversion of derivative security
-
8,529 Added 10.56%
72,205 Common Stock

Also insider at

MCD
MCDONALDS CORP Consumer Cyclical
JLT

Jennifer L Taubert

EVP, WWC. Innovative Medicine
New Brunswick, NJ

Track Institutional and Insider Activities on JNJ

Follow JOHNSON & JOHNSON and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JNJ shares.

Notify only if

Insider Trading

Get notified when an Johnson & Johnson insider buys or sells JNJ shares.

Notify only if

News

Receive news related to JOHNSON & JOHNSON

Track Activities on JNJ